Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 8/20 | 0.47 |
| ▸ | AURKB | Q96GD4 | 7/20 | 0.47 |
| ▸ | SRC | P12931 | 3/20 | 0.40 |
| ▸ | GSK3B | P49841 | 3/20 | 0.40 |
| ▸ | AURKC | Q9UQB9 | 1/20 | 0.40 |
| ▸ | PRKAB2 | O43741 | 4/20 | 0.37 |
| ▸ | PRKAG1 | P54619 | 4/20 | 0.37 |
| ▸ | PRKAA2 | P54646 | 4/20 | 0.37 |
| ▸ | PRKAA1 | Q13131 | 4/20 | 0.37 |
| ▸ | PRKAG3 | Q9UGI9 | 4/20 | 0.37 |
| ▸ | PRKAG2 | Q9UGJ0 | 4/20 | 0.37 |
| ▸ | PRKAB1 | Q9Y478 | 4/20 | 0.37 |
| ▸ | SYK | P43405 | 1/20 | 0.37 |
| ▸ | TNIK | Q9UKE5 | 2/20 | 0.37 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.35 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.35 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.35 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13220876 | 0.89 | AURKB (0.45) | AURKAAURKBSRCGSK3BAURKC | |
| SCHEMBL13220986 | 0.88 | AURKB (0.60) | AURKAAURKBSRCGSK3BAURKC | |
| SCHEMBL13220879 | 0.86 | AURKB (0.49) | AURKAAURKBSRCGSK3BAURKC | |
| SCHEMBL13221218 | 0.82 | AURKA (0.49) | AURKAAURKBSRCGSK3BAURKC | |
| SCHEMBL13220933 | 0.81 | AURKA (0.49) | AURKAAURKBSRCGSK3BAURKC | |
| SCHEMBL13220932 | 0.80 | AURKB (0.47) | AURKAAURKBSRCGSK3BAURKC | |
| SCHEMBL13221199 | 0.80 | AURKB (0.48) | AURKAAURKBSRCGSK3BAURKC | |
| SCHEMBL13220916 | 0.79 | AURKB (0.58) | AURKAAURKBSRCGSK3BAURKC | |
| SCHEMBL13221212 | 0.78 | AURKB (0.45) | AURKAAURKBSRCGSK3BAURKC | |
| SCHEMBL13221200 | 0.78 | AURKB (0.47) | AURKAAURKBSRCGSK3BAURKC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8288536-B2 | Kinase inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-10-16 | — | — | US | disclosed |
| US-8288536-B2 | Kinase inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-10-16 | — | — | US | disclosed |
| US-20100216765-A1 | KINASE INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-08-26 | — | — | US | disclosed |
| US-20100216765-A1 | KINASE INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-08-26 | — | — | US | disclosed |
| US-7713973-B2 | Kinase inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-05-11 | — | — | US | disclosed |
| US-7713973-B2 | Kinase inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216765-A1 | KINASE INHIBITORS | MAP3K20, MAP3K19, MAP3K1 | AURKA 161/4885AURKB 122/4885SRC 63/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.